Why is Transgene Biotek falling/rising?

As of 30-Jul, Transgene Biotek Ltd's stock price is currently at 4.48, reflecting a decrease of 0.2, or 4.27%. The stock has been underperforming, having fallen for the last three consecutive days, resulting in a total decline of 7.25% during this period. Additionally, the stock's performance over the past week shows a decline of 7.82%, while its year-to-date performance indicates a significant drop of 34.41%. The stock is currently trading above its 100-day moving average but below its 5-day, 20-day, 50-day, and 200-day moving averages. Furthermore, there has been a notable decrease in investor participation, with delivery volume dropping by 18.16% compared to the 5-day average, indicating reduced interest in trading the stock.
In the broader market context, Transgene Biotek's recent performance contrasts with the Sensex, which has only declined by 1.50% over the past week. This underperformance is evident as the stock has lost more value in the short term compared to the benchmark. Over the past month, Transgene Biotek has decreased by 2.61%, while the Sensex has seen a slight decline of 2.54%. The stark difference in year-to-date returns, with Transgene Biotek down 34.41% compared to the Sensex's gain of 4.28%, further highlights the challenges the company is facing in the current market environment.